Morphogenesis of the biliary tract
The production of bile is an essential function of the liver. It contains cholesterol, bile acids, pigments and electrolytes, and their concentration is modified when the bile transits through the biliary tract. The bile is produced by the hepatocytes and is secreted into the bile canaliculi. These canaliculi are delineated by the apical membrane of the hepatocytes and are connected to the network of intrahepatic bile ducts (IHBD). The bile flows from the IHBD to the hepatic ducts, transits through the cystic duct and is stored in the gallbladder. It is excreted in the gut via the common bile duct. The hepatic, cystic and common bile ducts are collectively termed extrahepatic bile ducts and like the gallbladder and IHBD, their lumen is delineated by specialized cells called biliary epithelial cells (BEC) or cholangiocytes. Much attention has been paid in the past decade to the molecular control of liver development (reviewed in Darlington, 1999; Duncan, 2000 Duncan, , 2002 Zaret, 2000) . However, the focus has mainly been on early liver development from the endoderm and on differentiation of hepatocytes. A number of recent papers now provide insight into the molecular mechanisms that regulate differentiation and morphogenesis of the biliary tract. Here we review these data and outline new questions on the molecular control of biliary development during embryogenesis.
The morphogenesis of the IHBD is similar in humans, rats and mice (Van Eyken et al., 1988a,b; Desmet and Callea, 1990) . A schematic description of this process is provided in Fig. 1 in which the timing corresponds to that in the mouse. Histologically, one can distinguish five steps in the development of the IHBD (Clotman et al., 2002) . In the first step, occuring around embryonic day (E) 13.5-14.5, a subset of hepatoblasts strongly expresses biliary-specific cytokeratins. These cells are located at the site where ducts form, close to the portal mesenchyme, and are therefore considered as biliary precursor cells (Van Eyken et al., 1988b; Germain et al., 1988; Shiojiri, 1984a,b; 1994) . At that stage, hepatoblasts expressing much lower levels of the same cytokeratins are also found throughout the parenchyma. In the second step, around E15.5, the biliary precursor cells form a continuous single-layered ring around the portal mesenchyme. This ring, now called ductal plate, becomes partly bilayered in the following step, which occurs around E16.5. In the fourth step, the ductal plate enters a phase of profound remodeling in which focal dilations appear between the two cell layers, giving rise to the bile ducts. The parts of the ductal plate not involved in the formation of the ducts progressively regress, and in the final stage, which starts around birth, the ducts are incorporated into the portal mesenchyme. Importantly, the formation of the IHBD occurs along a gradient from the hilum to the periphery of the liver. The timing of IHBD morphogenesis mentioned here corresponds to that of the most differentiated biliary structures found near the hilum.
As to the extrahepatic bile ducts and the gallbladder, their development is less well characterized. In humans, the liver primordium which emerges from the endoderm consists of a cranial portion and a caudal portion (Shiojiri, 1997) , and the extrahepatic bile ducts and the gallbladder arise from the latter portion. In mice, the boundary between these two portions is not well-defined.
Differentiation of BEC from hepatoblasts
The origin of the biliary cells has been much debated (reviewed in Shiojiri, 1997) , but the prevailing view is that biliary cells derive from bipotential hepatoblasts able to differentiate into hepatocytes or BEC. These conclusions were initially based on immunohistochemical data showing that nearly all early hepatoblasts express low levels of markers, such as specific cytokeratins or gamma-glutamyl transpeptidase, which later become strongly expressed in a www.elsevier.com/locate/modo biliary-specific way (Germain et al., 1988; Shiojiri, 1994) . Conversely, early biliary cells located near the portal tract transiently express albumin and a-foetoprotein, which are hepatoblast markers that later become restricted to hepatocytes (Shiojiri et al., 1991) .
The existence of bipotential precursors of hepatocytes and BEC in fetal liver was further suggested by transplantation experiments. In such experiments, fragments obtained from embryonic liver before the emergence of IHBD gave rise to hepatocytes and to typical bile ducts when transplanted into the testes of syngeneic animals (Shiojiri et al., 1991) . Several groups then attempted to isolate the precursors. Cell lines were isolated from wild-type E9.5 (Rogler, 1997) and E14 (M. Weiss, personal communication) mouse embryos or from embryos that express a constitutively active form of the HGF receptor (Spagnoli et al., 1998) . The cell lines expressed hepatoblast markers and could be induced under well-defined culture conditions to express biliary-specific or hepatocytespecific markers. Provided that their differentiation capacity is not acquired during the in vitro culture, the properties of the cells strongly suggest that biliary cells derive from bipotential hepatoblasts in vivo.
The evidence for the existence of bipotential hepatoblasts does not rule out the possibility that BEC may also derive from other embryonic cell types. In support of this, cells that display a wide differentiation capacity were isolated by flow cytometry from E13 mouse livers (Suzuki et al., 2002) . These cells were self-renewing and could differentiate into hepatocytes, BEC, pancreatic or intestinal cells and therefore behaved as pluripotent stem cells. Furthermore, in adults, liver and non-liver stem cells able to differentiate into hepatocytes and BEC were identified (see reviews by Weiss, Lagasse and Fausto in this issue). Whether the mechanisms involved in differentiation of these stem cells into BEC are similar to those operating during embryogenesis is not known. The relative contribution of liver stem cells and of non-hepatic cells to the development of the BEC during embryogenesis is also unknown. Taken together, these observations suggest that during embryogenesis the BEC mostly differentiate from hepatoblasts. Still, lineage studies that firmly establish the hepatoblastic origin of the BEC have not yet been performed. Targeted somatic gene rearrangements using the Cre recombinase in transgenic mice may help resolve this question. Fig. 1 . Morphogenesis of the intrahepatic bile ducts in the mouse. At E13.5-14.5, the biliary precursor cells, which express biliary-specific cytokeratins, are located close to the portal mesenchyme, and some hepatoblasts expressing low levels of biliary-specific cytokeratins are found throughout the parenchyma. Around E15.5, the biliary precursor cells form a continuous single-layered ring called ductal plate. The ductal plate becomes partly bilayered around E16.5. One day later, around E17.5, focal dilations appear between the two cell layers. These dilations give rise to the bile ducts, while the rest of the ductal plate progressively regresses. Around birth, the ducts become incorporated into the portal mesenchyme.
Mechanisms of BEC differentiation and formation of the ductal plate
The mechanisms that trigger the transition from a hepatoblast to a BEC are poorly understood and most differentiation models rely on descriptive work. However, recent data from our laboratory identified the onecut protein hepatocyte nuclear factor (HNF)-6 as the first transcription factor controlling the initiation of BEC differentiation (Clotman et al., 2002) . In foetal liver, HNF-6 is strongly expressed in the hepatoblasts and BEC, but not in the mesenchyme. In transgenic Hnf62/2 embryos at E13.5, numerous hepatic cells expressing high levels of biliary-specific cytokeratins were observed, while a few were found in wild-type embryos. This indicates that HNF-6 regulates the number of cells entering the BEC differentiation pathway. At the same stage, the expression of the homeodomain transcription factor HNF-1b was markedly reduced in Hnf62/2 embryos. The HNF-1b promoter is a direct target of HNF-6 and at later stages of liver development, Hnf1b 2/2 mice showed biliary anomalies that mimic those found in Hnf62/2 embryos (Coffinier et al., 2002) . These data, therefore, suggest that a HNF-6 ! HNF-1b cascade regulates the onset of BEC differentiation. However, since the phenotype of the Hnf1b 2/2 mice has not been investigated at the onset of BEC differentiation, the involvement of HNF-1b at this stage remains speculative.
In Hnf62/2 embryos at E13.5, the BEC were found near the portal mesenchyme but they also formed cord-like extensions within the liver parenchyma (Clotman et al., 2002) . HNF-6 is, therefore, required not only to restrict BEC differentiation but also to confine BEC differentiation to the vicinity of the portal mesenchyme.
The mesenchyme is, since a long time, suspected to play a key role in BEC differentiation (reviewed in Shiojiri, 1997) . Differentiation of hepatoblasts into BEC was stimulated when co-cultured with lung mesenchyme (Shiojiri and Koike, 1997) . More recently, the role of the mesenchyme in the development of BEC was demonstrated by the analysis of mice haploinsufficient for FoxF1, which is a transcription factor expressed in gallbladder mesenchyme. The gallbladder BEC were absent in a subset of heterozygous Foxf11/2 mice (Kalinichenko et al., 2002) . FoxF1 is not expressed in the portal mesenchyme and, consistent with this, IHBD development appeared to be normal in the Foxf11/2 mice. While these data indicate that the mesenchyme controls BEC development, mesenchyme development is in turn controlled by the BEC. Indeed, in Hnf62/2 mice, the development of the mesenchyme is perturbed (our unpublished data).
Because of their close association with differentiating ductal plate cells, extracellular matrix components of the portal mesenchyme are suspected to control BEC differentiation via cell-matrix interactions. These components include laminin, fibronectin and collagen types I and IV (Shah and Gerber, 1990; Baloch et al., 1992; Terada and Nakanuma, 1994; Amenta and Harrison, 1997) . The expression of extracellular matrix receptors was investigated in human BEC, both in adults and in fetuses (Couvelard et al., 1998; Volpes et al., 1991) . During development, a switch in the expression of integrin receptors was observed when the hepatoblasts differentiated into BEC. Hepatoblasts expressed integrin heterodimers containing the b1 subunit (a1b1, a5b1, a6b1 and a9b1), while the BEC of the ductal plate showed a progressive increase in a6b1 and a decrease in a1b1. In addition, the ductal plate cells started to express the a2b1, a3b1, aVb1 and a6b4 integrins, which were not found in the hepatoblasts. The increase in a6b1 expression and the biliary-specific expression of a2b1, a3b1and a6b4, which are laminin receptors, correlated with the presence of laminin at the contact points of the portal mesenchyme with the BEC (Couvelard et al., 1998) .
Besides cell-matrix interactions, molecules involved in cell-cell interactions were investigated during BEC differentiation. The expression of E-cadherin, a-catenin and bcatenin was investigated during the development of human bile ducts (Terada et al., 1998 ). E-cadherin was found in ductal plate cells, but its predominant expression in the cytoplasm does not seem to be compatible with a role in BEC differentiation. In contrast, a-catenin showed a strong membraneous expression pattern in the ductal plate. N-CAM, a cell adhesion molecule involved in both cell-cell and cell-matrix contacts, may play a transient role at the early stages of BEC differentiation. Indeed, N-CAM was expressed in the membrane of BEC at the single-layered stage of the ductal plate (Fabris et al., 2000) . This expression then gradually decreased. The BEC of the doublelayered and remodeling ductal plate showed only patchy N-CAM expression, and in mature BEC no N-CAM was detected (Fabris et al., 2000; Libbrecht et al., 2001 ). These correlative data suggest that cell-matrix and cellcell interactions regulate BEC differentiation.
Remodeling of the ductal plate and morphogenesis of intrahepatic biliary ducts
When BEC became organized to form a single-layered ductal plate, a second layer is formed. This may take place by the division of the BEC from the first layer in an orientation-dependent manner. However, very few BEC were found to express the proliferation marker Ki-67 in the ductal plate (Clotman et al., 2002 , Fabris et al., 2000 . Proliferative activity is found later, when ducts integrate into the mesenchyme. If division of cells from the single-layered ductal plate does not occur, the second layer may form by a wave of differentiation of BEC from hepatoblasts. In this case, the mechanism of differentiation of these BEC is likely to differ from that operating during differentiation of the first layer. Indeed, the second layer of the ductal plate is separated from the portal mesenchyme by the first layer of cells, and therefore it differentiates within a different environment.
The remodeling of the double-layered ductal plate leads to the disappearance of most of the ductal plate and the formation of the primitive IHBD. How does this remodeling occur? In humans, the double-layered ductal plate seems to regress by apoptosis . First, high levels of the anti-apoptotic protein Bcl-2 were detected in the single-layered ductal plate and its concentration gradually decreased when the ductal plate underwent remodeling Fabris et al., 2000) . A second argument is provided by the Meckel syndrome, an inherited autosomal recessive disease affecting several organs including the liver (OMIM 249000). In the newborn patients, the development of the IHBD is arrested at the ductal plate stage, and the analysis of fetuses affected by the disease showed a significantly lower apoptotic rate in the ductal plate (Sergi et al., 2000) .
The role of cell-cell and cell-matrix interactions in BEC differentiation has been discussed above. Similar interactions may also be required to control the remodeling of the ductal plate. b-Catenin expression increases while Ecadherin expression decreases during remodeling of the ductal plate (Terada et al., 1998) , indicating that cell-cell interactions are tightly controlled in this process. The composition of the extracellular matrix is also regulated by time-and site-specific cues. For instance, tenascin is found specifically at the interface between the mesenchyme and the BEC of the primitive ducts that migrate into the mesenchyme, but it is absent near the ductal plate cells that are not involved in tubule formation (Terada and Nakanuma, 1994) . Of note, tenascin was found near the developing hilar ducts, and not near the peripheral ducts. This suggests that cell-matrix interactions not only control morphogenesis of the ducts, but also the differentiation of subtypes of BEC. Subtypes of BEC, classified on a morphometric basis, were indeed characterized at the molecular level. The secretin receptor, the Cl-/HCO 3 -exchanger, and the cystic fibrosis transmembrane conductance regulator are present in BEC delineating medium and large ducts but not small ducts (Alpini et al., 1996) .
During the remodeling phase, it is commonly considered that the ducts migrate into the mesenchyme. This would require the coordinated expression of matrix proteinases and of inhibitors thereof. In support of this, MMP-1, TIMP-1 and TIMP-2 are expressed by the biliary duct cells Quondamatteo et al., 1999) . However, the possibility remains that the ducts do not invade the mesenchyme but that the mesenchyme proliferates around the ducts.
The control of bile duct morphogenesis by cell-cell and cell-matrix interactions may also involve soluble factors. Convincing evidence is derived from experiments in which primary human BEC become organized in ducts when co-cultured with hepatocytes in double collagen gels. A similar ductal morphogenesis was observed when the BEC were grown in the presence of conditioned medium from previous co-cultures of hepatocytes and BEC, suggesting that soluble factors secreted by the BEC or by the hepatocytes are required for tubulogenesis . Furthermore, hepatocyte aggregates started to express the bile duct marker cytokeratin 19 and formed luminal structures when embedded in collagen gel and cultured with a fibroblast-conditioned medium (Nishikawa et al., 1996) . In this system, insulin induced a similar morphogenesis and this effect was enhanced by the mitogens EGF and HGF. While the the role of HGF in proliferation is well-documented, its morphogenic role is not yet clear. Different interpretations were given depending on the culture conditions or the cell type tested. HGF had no morphogenic role on hepatocyte aggregates grown in collagen gel (Nishikawa et al., 1996) . In contrast, evidence for a tubulogenic role of HGF was shown in cultures of non-parenchymal hepatic cell lines and of human BEC in collagen gels (Johnson et al., 1993; Ishida et al., 2001 ). Also, a combination of HGF and EGF induced proliferation and differentiation of primary hepatocytes into cytokeratin 19-expressing cells (Block et al., 1996) . To sum up, a number of in vitro studies report the role of soluble factors in morphogenesis of bile ducts. These studies have no in vivo counterpart yet and were performed with cell lines or with primary cultures of cells that had already reached a differentiated state. Whether these observations pertain to in vivo morphogenesis during development remains to be investigated.
Developmental relationships between ducts, vasculature and mesenchyme of the portal tract
A number of human diseases, collectively termed 'ductal plate malformations' (reviewed in Desmet, 1992) , are histologically characterized by the presence of biliary structures in ductal plate configuration, as was seen in the Hnf62/2 and Hnf1b2/2 mice (Clotman et al., 2002; Coffinier et al., 2002) . These diseases include some forms of biliary atresia, Caroli's disease, Meckel syndrome as well as diseases associated with well-defined gene defects such as Alagille syndrome, and the recessive and dominant forms of polycystic kidney disease. In ductal plate malformations, abnormal biliary ducts are often associated with anomalies of the portal mesenchyme and of the portal blood vessels, which suggest a functional interaction between the components of the portal tract. There is a recent descriptive evidence for interactions between ducts and arteries. Indeed, the appearance of a-smooth muscle actinpositive cells around the ducts and their organization to form the arterial wall is tightly correlated with bile duct development (Libbrecht et al., 2002) .
The strongest evidence for functional interactions between mesenchyme, ducts and blood vessels is found in humans and mice showing defects in the Notch pathway. The Alagille syndrome (OMIM #118450) is an autosomal dominant disease characterized by abnormal development of several organs. Histopathology of the liver shows intra-hepatic ductal paucity and cholestasis in the majority of patients (Emerick et al., 1999) . In portal tracts that are devoid of bile ducts, one observes an increased number of arteries and fibrosis. Alagille syndrome is associated with haploinsufficiency of Jagged-1, a Notch receptor ligand (Li et al., 1997; Oda et al., 1997) . In humans, Jagged-1 was found in the ductal plate and it persisted in the ductal epithelium throughout life (Louis et al., 1999) . It was also detected in endothelial cells of the developing portal vasculature (Crosnier et al., 2000) , but this expression was not maintained in the adult. In mice, the Jagged-1 homolog showed a different liver expression pattern. It was detected in endothelial and non-endothelial cells of the hepatic arteries and portal vein, but not in bile duct epithelium (McCright et al., 2002) . The differences in Jagged-1 expression between human and mouse most likely reflect species-specificity rather than technical artifacts, since mice heterozygous or homozygous for a targeted null mutation in the Jagged1 gene did not show the liver symptoms of Alagille syndrome (Xue et al., 1999) . In contrast, double heterozygous mice for mutations in the Jagged1 and Notch2 genes exhibited a spectrum of abnormalities found in Alagille syndrome (McCright et al., 2002) . These mice showed the absence of bile ducts in the portal tract combined with portal fibrosis. Notch-2 is a receptor for Jagged-1 and in mice it was detected in cells located in the vicinity of Jagged1-expressing cells, namely in mesenchymal cells that surround the portal vein, the hepatic artery and the bile ducts, but not BEC (McCright et al., 2002) . This again contrasts with the distribution pattern in humans where Notch-2 was detected in the BEC, the hepatocytes and the endothelium of the blood vessels (Nijjar et al., 2001 ). Interestingly, homozygous Notch2 null mutant mice displayed the same biliary abnormalities as those observed in the Jagged1/Notch2 double heterozygous mice (McCright et al., 2002) .
Despite the discrepancies between the human and murine expression patterns for Notch and Jagged, it is clear that the defects in the Notch pathway affect the morphology of IHBD. However, the stage at which the Notch pathway is involved in biliary development is not well-defined. Longitudinal studies on Alagille-syndrome-affected patients with serial biopsies indicated that bile ducts are not congenitally lacking but that the ductal paucity develops progressively after birth (Desmet and Callea, 1990) . These data would support a model in which the Notch pathway is required to maintain a differentiated phenotype, rather than to initiate differentiation and morphogenesis. In contrast, in mice, the phenotype of Jagged1-and Notch2-deficient mice was investigated in the early postnatal period, and the ducts were already absent. This would support a role of the Notch pathway during embryogenesis. Further analysis is needed to clarify the role of the Notch pathway in biliary development and to claim that the Jagged1/Notch2 double heterozygous mice do indeed represent a murine model for human Alagille syndrome.
In Jagged-1-and Notch-2-deficient mice, the biliary anomalies are non-cell autonomous. IHBD development is, therefore, controlled by the portal blood vessels and by mesenchymal cells. Conversely, the BEC exert a control on the development of the blood vessels of the portal tract. Indeed, the absence of HNF-1b or HNF-6, two factors strongly expressed themselves in the BEC but not in the blood vessels, induced vascular defects. HNF-1b-deficient mice showed no arteries in the portal tract (Coffinier et al., 2002 ) and HNF-6-deficient mice displayed anomalies of the hepatic arteries and of the peribiliary capillary plexus (our unpublished data). To sum up, sufficient mechanistic data are now available to conclude the fact that development of bile ducts, hepatic arteries and mesenchyme is tightly cross-regulated. Whether hepatoblasts and hepatocytes participate in this cross-regulation has not yet been investigated (Fig. 2) .
Conclusions
A large amount of descriptive data on the morphogenesis Data from transgenic mice show that HNF-6 and HNF-1b, which are expressed in BEC, control BEC, blood vessel and mesenchyme development. The Notch-mediated interactions between the blood vessels and the mesenchyme control BEC differentiation and/or bile duct morphogenesis. FoxF1, which is expressed in the gallbbladder mesenchyme, is required for the development of the gallbladder epithelium. A putative role for the hepatocytes, the extracellular matrix (ECM) and growth factors is postulated.
of the biliary tract has been collected in the past two decades. These studies identified a number of molecules as candidates for the control of biliary differentiation and morphogenesis, based on the observation that their expression correlates with one or another step of biliary development. The recent identification of genes responsible for human diseases and the phenotypic analysis of transgenic mice have demonstrated the involvement of transcription factors and signalling pathways in biliary development. New transgenic mice should allow to test the role of additional proteins. We have also underlined how tightly the development of bile ducts, portal vasculature and portal mesenchyme is cross-regulated. Thus, culture systems that maintain an association between ducts, blood vessels and mesenchyme are required to further elucidate the mechanisms controlling bile duct development. Unravelling these mechanisms is critical to understand the pathogenesis of human biliary malformations.
